Alignment Healthcare, Inc. (NASDAQ:ALHC) Receives Average Recommendation of “Moderate Buy” from Analysts

Shares of Alignment Healthcare, Inc. (NASDAQ:ALHC) have been given an average recommendation of “Moderate Buy” by the eleven ratings firms that are covering the firm, Marketbeat reports. One research analyst has rated the stock with a sell rating, two have issued a hold rating, seven have issued a buy rating and one has assigned a strong buy rating to the company. The average 12-month target price among brokerages that have covered the stock in the last year is $11.88.

A number of equities research analysts recently weighed in on the stock. Stifel Nicolaus lifted their price objective on shares of Alignment Healthcare from $14.00 to $16.00 and gave the company a “buy” rating in a report on Tuesday, January 14th. UBS Group lifted their price objective on shares of Alignment Healthcare from $9.00 to $12.00 and gave the company a “neutral” rating in a report on Wednesday, October 30th. Barclays lifted their price objective on shares of Alignment Healthcare from $7.00 to $8.00 and gave the company an “underweight” rating in a report on Wednesday, October 30th. Finally, Stephens reiterated an “overweight” rating and set a $17.00 price objective on shares of Alignment Healthcare in a report on Thursday, January 2nd.

Alignment Healthcare Price Performance

Alignment Healthcare stock opened at $13.68 on Tuesday. Alignment Healthcare has a 12-month low of $4.46 and a 12-month high of $15.82. The firm has a 50-day moving average price of $13.00 and a 200-day moving average price of $11.67. The firm has a market capitalization of $2.62 billion, a PE ratio of -17.77 and a beta of 1.50. The company has a current ratio of 1.60, a quick ratio of 1.60 and a debt-to-equity ratio of 1.82.

Insider Activity

In other news, insider Hakan Kardes sold 35,000 shares of Alignment Healthcare stock in a transaction that occurred on Wednesday, November 27th. The shares were sold at an average price of $12.80, for a total value of $448,000.00. Following the transaction, the insider now owns 320,444 shares of the company’s stock, valued at $4,101,683.20. The trade was a 9.85 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, COO Sebastian Burzacchi sold 8,550 shares of Alignment Healthcare stock in a transaction that occurred on Tuesday, December 10th. The stock was sold at an average price of $11.26, for a total transaction of $96,273.00. Following the completion of the transaction, the chief operating officer now directly owns 217,395 shares in the company, valued at approximately $2,447,867.70. The trade was a 3.78 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 446,002 shares of company stock worth $5,809,126. 6.60% of the stock is currently owned by corporate insiders.

Institutional Trading of Alignment Healthcare

Large investors have recently bought and sold shares of the stock. R Squared Ltd purchased a new stake in Alignment Healthcare during the 4th quarter worth approximately $55,000. nVerses Capital LLC purchased a new stake in shares of Alignment Healthcare in the 3rd quarter valued at $95,000. RiverPark Advisors LLC purchased a new stake in shares of Alignment Healthcare in the 4th quarter valued at $106,000. Tower Research Capital LLC TRC boosted its holdings in shares of Alignment Healthcare by 146.7% in the 4th quarter. Tower Research Capital LLC TRC now owns 10,571 shares of the company’s stock valued at $119,000 after acquiring an additional 6,286 shares during the last quarter. Finally, Ballentine Partners LLC purchased a new stake in shares of Alignment Healthcare in the 4th quarter valued at $121,000. Hedge funds and other institutional investors own 86.19% of the company’s stock.

About Alignment Healthcare

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.